Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in Chinese patients with ischemic cardiomyopathy
ChiCTR1800018905Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan and benazepril in ischaemic cardiomyopathy (ICM) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: cardiac death and rehospitalization due to heart failure. Started Oct 2018; status: recruiting.
02
Drugs
sacubitril + valsartanbenazepril
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on ChiCTR1800018905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018905.